57 related articles for article (PubMed ID: 16425184)
21. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
Yu S; Wang Y; Yuan H; Zhao H; Lv W; Chen J; Wan F; Liu D; Gao Z; Wu J
PLoS One; 2017; 12(1):e0171134. PubMed ID: 28125713
[TBL] [Abstract][Full Text] [Related]
22. High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.
Barreiro-Alonso A; Lamas-Maceiras M; Rodríguez-Belmonte E; Vizoso-Vázquez Á; Quindós M; Cerdán ME
Oxid Med Cell Longev; 2016; 2016():5845061. PubMed ID: 26682011
[TBL] [Abstract][Full Text] [Related]
23. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
24. The natural tumorcide Manumycin-A targets protein phosphatase 1α and reduces hydrogen peroxide to induce lymphoma apoptosis.
Carey GB; Roy SK; Daino H
Exp Cell Res; 2015 Mar; 332(1):136-45. PubMed ID: 25556058
[TBL] [Abstract][Full Text] [Related]
25. TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Saikumar P
Genes Cancer; 2014 Sep; 5(9-10):320-36. PubMed ID: 25352949
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues.
Smith DA; Kiba A; Zong Y; Witte ON
Mol Cancer Res; 2013 Oct; 11(10):1159-65. PubMed ID: 23867565
[TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide-3-kinases p110α and p110β mediate S phase entry in astroglial cells in the marginal zone of rat neocortex.
Müller R; Fischer C; Wilmes T; Heimrich B; Distel V; Klugbauer N; Meyer DK
Front Cell Neurosci; 2013; 7():24. PubMed ID: 23504389
[TBL] [Abstract][Full Text] [Related]
28. Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2.
Wang Z; Inuzuka H; Zhong J; Liu P; Sarkar FH; Sun Y; Wei W
Oncotarget; 2012 Nov; 3(11):1294-300. PubMed ID: 23230084
[TBL] [Abstract][Full Text] [Related]
29. Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.
Wu J; Lee SW; Zhang X; Han F; Kwan SY; Yuan X; Yang WL; Jeong YS; Rezaeian AH; Gao Y; Zeng YX; Lin HK
Oncogene; 2013 Jan; 32(1):78-85. PubMed ID: 22310285
[TBL] [Abstract][Full Text] [Related]
30. Skp2 is a promising therapeutic target in breast cancer.
Wang Z; Fukushima H; Inuzuka H; Wan L; Liu P; Gao D; Sarkar FH; Wei W
Front Oncol; 2012 Jan; 1(57):. PubMed ID: 22279619
[TBL] [Abstract][Full Text] [Related]
31. Skp2: a novel potential therapeutic target for prostate cancer.
Wang Z; Gao D; Fukushima H; Inuzuka H; Liu P; Wan L; Sarkar FH; Wei W
Biochim Biophys Acta; 2012 Jan; 1825(1):11-7. PubMed ID: 21963805
[TBL] [Abstract][Full Text] [Related]
32. Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells.
Rico-Bautista E; Yang CC; Lu L; Roth GP; Wolf DA
BMC Biol; 2010 Dec; 8():153. PubMed ID: 21182779
[TBL] [Abstract][Full Text] [Related]
33. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.
Xiao D; Singh SV
Pharm Res; 2010 Apr; 27(4):722-31. PubMed ID: 20182772
[TBL] [Abstract][Full Text] [Related]
34. Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1.
Gao D; Inuzuka H; Tseng A; Wei W
Cell Div; 2009 Jun; 4():11. PubMed ID: 19549334
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.
Gao D; Inuzuka H; Tseng A; Chin RY; Toker A; Wei W
Nat Cell Biol; 2009 Apr; 11(4):397-408. PubMed ID: 19270695
[TBL] [Abstract][Full Text] [Related]
36. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
37. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
38. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
[TBL] [Abstract][Full Text] [Related]
39. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
Murillo H; Huang H; Schmidt LJ; Smith DI; Tindall DJ
Endocrinology; 2001 Nov; 142(11):4795-805. PubMed ID: 11606446
[TBL] [Abstract][Full Text] [Related]
40. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway].
Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
